Clinical Study
Clinical Analysis of Ocular Parameters Contributing to Intraoperative Pain during Standard Phacoemulsification
Table 2
Baseline characteristics of patients undergoing phacoemulsification.
| | Characteristics | Value |
| | Number of eyes, n (%) | | OD | 68 (47.9%) | | OS | 74 (52.1%) | | Sex, n (%) | | Male | 70 (49.3%) | | Female | 72 (50.7%) | | Age, years | 67.49 ± 12.50 | | Underlying disease, n (%) | | Diabetes mellitus | 40 (28.2%) | | Hypertension | 45 (31.7%) | | Benign prostatic hyperplasia | 6 (4.2%) | | Retinal disease | 28 (19.7%) | | Glaucoma | 32 (22.5%) | | Anterior chamber depth, mm | 3.09 ± 0.39 | | Axial length, mm | 23.77 ± 1.76 | | Intraocular pressure, mmHg | 14.46 ± 3.10 | | LogMAR BCVA | 0.70 ± 0.63 | | Central corneal thickness, μm | 432 ± 228 | | Endothelial cell density, cells/mm2 | 2631 ± 483 | | Nuclear cataract grading | 3.69 ± 1.25 |
|
|
Values are presented as the mean ± SD. BCVA: best-corrected visual acuity.
|
